27 /100
MEDIUM RISK
Score updated May 30, 2026

INTI — Inhibitor Therapeutics, Inc. Dilution Risk Tracker

Track INTI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track INTI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
40
⚠️ Warrant Exposure
70
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
42%
🔄 Reverse Split 55%
• 50-day avg $0.09 below $1 exchange minimum
📜 Warrant Exercise 50%
• Massive warrant overhang: 31% of shares outstanding
• Elevated warrant risk score (70/100)
🔔 Track INTI — Get forecast alerts →

💹 Market Data

Market Cap$14.67M
Shares Outstanding172.57M
FloatN/A
Cash$1.29M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest17.1K
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2018
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track INTI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking INTI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for INTI
📊 INTI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 INTI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.